Jyoti Rajeev, Jain Tarun Pankaj, Haxhimolla Hodo, Liddell Heath, Barrett Sean Edward
Universal Medical Imaging, Canberra, Calvary Hospital, Bruce, Australia.
Australian National University, Canberra, ACT, Australia.
Eur J Radiol Open. 2018 Mar 30;5:58-63. doi: 10.1016/j.ejro.2018.03.002. eCollection 2018.
The purpose was to investigate the usefulness of ADC on Diffusion MRI to discriminate between benign and malignant lesions of Prostate.
Images of patients who underwent in-gantry MRI guided prostate lesion biopsy were retrospectively analyzed. Prostate Cancers with 20% or more Gleason score (GS) pattern 3 + 3 = 6 in each core or any volume of higher Gleason score pattern were included. ADC was calculated by two reviewers for each lesion. The ADC was calculated for each lesion by dividing the lowest ADC value in a lesion and highest ADC value in normal prostate in peripheral zone (PZ). ADC values were compared with the biopsy result. Data was analysed using independent samples T-test, Spearman correlation, intra-class correlation coefficient (ICC) and Receiver operating characteristic (ROC) curve.
45 lesions in 33 patients were analyzed. 12 lesions were in transitional zone (TZ) and 33 in perpheral zone PZ. All lesions demonstrated an ADC of 0.45 or lower. GS demonstrated a negative correlation with both the ADC value and ADC. However, ADC (p < 0.001) demonstrated a stronger correlation compared to ADC value alone (p = 0.014). There was no significant statistical difference between GS 3 + 4 and GS 4 + 3 mean ADC value (p = 0.167). However when using ADC, there was a significant difference (p = 0.032). ROC curve analysis demonstrated an area under the curve of 0.83 using ADC and 0.76 when using ADC value when discriminating Gleason 6 from Gleason ≥7 tumours. Inter-observer reliability in the calculation of ADC ratios was excellent, with ICC of 0.964.
ADC is a reliable and reproducible tool in quantification of diffusion restriction for clinically significant prostate cancer foci.
本研究旨在探讨扩散加权磁共振成像(Diffusion MRI)中的表观扩散系数(ADC)在鉴别前列腺良恶性病变中的应用价值。
回顾性分析在MRI引导下进行前列腺病变活检患者的图像。纳入标准为每个穿刺针芯中Gleason评分(GS)模式3+3=6占比20%或更多,或存在任何体积的更高Gleason评分模式的前列腺癌患者。两名阅片者分别计算每个病变的ADC值。通过将病变内最低ADC值除以周围带(PZ)正常前列腺组织中的最高ADC值来计算每个病变的ADC值。将ADC值与活检结果进行比较。采用独立样本t检验、Spearman相关性分析、组内相关系数(ICC)和受试者工作特征(ROC)曲线进行数据分析。
分析了33例患者的45个病变。其中12个病变位于移行带(TZ),33个病变位于外周带(PZ)。所有病变的ADC值均≤0.45。GS与ADC值及ADC均呈负相关。然而,与单独的ADC值(p=0.014)相比,ADC(p<0.001)显示出更强的相关性。GS 3+4和GS 4+3的平均ADC值之间无显著统计学差异(p=0.167)。然而,使用ADC时存在显著差异(p=0.032)。ROC曲线分析显示,在鉴别Gleason 6级与Gleason≥7级肿瘤时,使用ADC的曲线下面积为0.83,使用ADC值时为0.76。ADC比值计算的观察者间可靠性极佳,ICC为0.964。
ADC是一种可靠且可重复的工具,用于定量评估具有临床意义的前列腺癌病灶的扩散受限情况。